ClinicalTrials.gg
CompletedNCT00137644Updated May 11, 2026

Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents

A Phase 1/2 interventional study of Preventing AIDS Through Live Movement and Sound (PALMS) in Hiv, sponsored by Centers for Disease Control and Prevention. Completed at 1 site in United States. Open to male participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Centers for Disease Control and Prevention · Phase 1/2, Interventional, and Prevention

Phase
Phase 1/2
Study type
Interventional
Enrollment
264
Allocation
Non-randomized
Ages
12 Years to 18 Years
Sex
Male
01

Study summary

The purpose of this program evaluation is to determine whether the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing of high-risk, incarcerated or adjudicated youth. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

Read the detailed description

Philadelphia Health Management Corporation (PHMC) is evaluating the Preventing AIDS Through Live Movement and Sound (PALMS) group-level intervention for high-risk, incarcerated or adjudicated youth. PALMS uses three theater-based sessions to increase knowledge about HIV/AIDS, increase HIV testing, and reduce risky sexual behavior through increased self-efficacy. The intervention is delivered by peers, and peers work with the intervention team to use evaluation results to improve the program. The evaluation will recruit male adolescents, aged 12 to 18 years, who are residing in juvenile justice or drug treatment facilities in Philadelphia. The evaluation design uses concurrent intervention (N=132) and comparison (N=132) groups. Data will be collected at baseline, immediate post-intervention, and at a 6-month post-intervention follow-up. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.

02

Conditions studied

  • Hiv

Keywords

  • Adolescent
  • *HIV Infections/ pc [Prevention & Control]
  • Male
  • Humans
  • Risk-Taking
  • Safe Sex
  • Sexual Behavior
  • HIV
  • HIV Seronegativity
03

In context

Acquired Immunodeficiency Syndrome

3,035 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 306 are open to participants now.

This study's enrollment of 264 is above the median of 96 across 2,251 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

Centers for Disease Control and Prevention is the lead sponsor of 275 studies on the registry; 2 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 8 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male adolescents
  • Between the ages of 12 and 18
  • Receiving residential services at juvenile justice or drug treatment facilities
  • African-American or Latino

Exclusion criteria

Exclusion Criteria:

  • Do not speak English
  • Prior participation in PALMS intervention
  • Female adolescents
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
264 participants (actual)

Interventions

  • BehavioralPreventing AIDS Through Live Movement and Sound (PALMS)
06

What researchers measure

Primary outcomes

  1. Sexual activity

    Time frame: Within past 3 months & ever

  2. Number and type (main and non-main) of female sex partners

    Time frame: Within past 3 months

  3. Frequency of condom use with female sex partners

    Time frame: Within past 3 months

  4. HIV testing (ever tested, number of tests, likelihood of test)

    Time frame: Within past 3 months

Secondary outcomes

  1. Drug use

    Time frame: Within past 3 months

  2. Knowledge of HIV transmission, prevention and testing

    Time frame: Concurrent

  3. Attitudes and beliefs about condoms and safe sex

    Time frame: Concurrent

  4. Beliefs about HIV and HIV testing

    Time frame: Concurrent

  5. Perception of HIV risk

    Time frame: concurrent

  6. Self-efficacy to use condoms and practice safe sex

    Time frame: Concurrent

  7. Self-esteem

    Time frame: Concurrent

  8. Perceptions of cultural and peer norms

    Time frame: Concurrent

07

Study locations

1 site
  • Philadelphia Health Management Corporation
    Philadelphia, Pennsylvania 19102, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00137644
Collaborators
Public Health Management Corporation
First posted
Aug 30, 2005
Start date
Mar 2005
Completion
Jan 2007
Last update
May 11, 2026

Study contacts

Jennifer Lauby, PhD
principal investigator · Public Health Management Corporation
Jeffrey H Herbst, PhD
Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention
Thomas M Painter, PhD
Project Officer, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control and Prevention

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion